drugset / Trial / NCT00037544
Study Evaluating ReFacto AF in Severe Hemophilia A
Treatment
Summary
To characterize the safety and efficacy of ReFacto AF in treating acute bleeding episodes during prophylaxis treatment, including neoantigenicity.
Timeline
- Start
- —
- Primary completion
- 2004-08
- Completion
- 2004-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moroctocog alfa | Protein / enzyme biologic | — | — |